Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CLARINET LT: Clopidogrel in Infants with Cyanotic Congenital Heart Disease
NCT00833703Phase 3Completed
- Sponsor
- Sanofi
- Start
- Jan 2009
- Primary completion
- Jul 2010
- Modality
- Small Molecules
- Countries
- 15
01
Overview
A Phase 3 trial of clopidogrel in cyanotic congenital heart disease (CCHD), sponsored by Sanofi. Started Jan 2009; status: completed.
02
Drugs
clopidogrel
03
Conditions
cyanotic congenital heart disease (CCHD)
Beyond the preview
Go deeper on NCT00833703.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00833703.